New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies COLUMBUS, Ohio, March 9, 2026 /PRNewswire/ -- CoverMyMeds today ...
U.S. net product revenue in first full year Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026 ...
A class action lawsuit against UnitedHealthcare claims that an AI system was used to unfairly deny post-acute rehabilitation ...
The situation in Ecuador under Daniel Noboa’s government is one of authoritarianism advancing on several fronts ...
U.S. net product revenue in first full year Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026 Strong balance sheet of $245.0 million in ...